iCAD Inc - Strategic SWOT Analysis Review

iCAD Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Report Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The analyst’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

iCAD Inc (iCAD), a subsidiary of RadNet Inc, is a medical technology company that provides AI-powered cancer detection technologies. The company develops and markets solutions for cancer detection and risk assessment. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. Its major product is the ProFound Breast Health Suite, which includes solutions for breast cancer detection, density assessment, and cardiovascular risk evaluation. The company uses artificial intelligence for its product development. iCAD operates in the US and markets products through direct sales organizations, OEM partners with Google Health, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.

iCAD Inc Key Recent Developments

• May 06, 2025: RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹
• Apr 17, 2025: RadNet’s DeepHealth strikes $103m deal to acquire iCAD
• Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.